Patent · US Active

Crystal form of neratinib maleate and preparation method therefor

US10246437B2 · kind B2 · utility

0Cited by
4References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 8, 2016
Grant dateApr 2, 2019
Priority date
Expiry dateJan 8, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to novel crystalline forms of Neratinib maleate and the preparation method thereof. The novel crystalline forms of Neratinib maleate in the present invention have high solubility, good stability, good processability, easy post-treatment process and other favorable properties. The preparation method is simple, low cost, and has an important value for future optimization and development of the drug.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.